SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-21-002166
Filing Date
2021-03-01
Accepted
2021-03-01 08:20:15
Documents
85
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6-k.htm 6-K 22612
2 CONSENTS OF EXPERTS AND COUNSEL ex231.htm EX-23.1 4479
3 EXHIBIT 99.1 ex991.htm EX-99.1 795098
4 EXHIBIT 99.2 ex992.htm EX-99.2 1507693
5 EXHIBIT 99.3 ex993.htm EX-99.3 336417
6 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
7 IMAGE mnp_logo.jpg GRAPHIC 2454
  Complete submission text file 0001654954-21-002166.txt   6619146

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ipci-20201130.xml EX-101.INS 1000539
9 XBRL TAXONOMY EXTENSION SCHEMA ipci-20201130.xsd EX-101.SCH 62986
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipci-20201130_cal.xml EX-101.CAL 64688
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipci-20201130_def.xml EX-101.DEF 124086
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipci-20201130_lab.xml EX-101.LAB 360215
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipci-20201130_pre.xml EX-101.PRE 266667
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 21693920
SIC: 2834 Pharmaceutical Preparations